AJỤỌ1

nwamba # Aha ngwaahịa Nkọwa
CPD100608 ASK1-Inhibitor-10 ASK1 Inhibitor 10 bụ ihe mgbochi ọnụ nke nwere ike ime ihe mgbochi apoptosis na-achịkwa kinase 1 (ASK1). Ọ bụ nhọrọ maka ASK1 karịa ASK2 yana MEKK1, TAK-1, IKKβ, ERK1, JNK1, p38α, GSK3β, PKCθ, na B-RAF. Ọ na-egbochi mmụba nke streptozotocin na-ebute na JNK na p38 phosphorylation na mkpụrụ ndụ β pancreatic nke INS-1 n'ụzọ dabere na ntinye uche.
CPD100607 K811 K811 bụ ihe mgbochi ASK1 akọwapụtara nke na-agbatị ndụ n'ụdị òké nke sclerosis nke amyotrophic. K811 gbochiri nke ọma mmụba cell n'ahịrị sel nwere okwu ASK1 dị elu yana n'ime sel HER2-overexpressing GC. Ọgwụgwọ na K811 belatara nha etuto xenograft site na iwetu akara nrịbawanye.
CPD100606 K812 K812 bụ ihe mgbochi ASK1 akọwapụtara ka ọ ga-adị ogologo ndụ n'ụdị òké nke sclerosis nke amyotrophic.
CPD100605 MSC-2032964A MSC 2032964A bụ onye nwere ike na nhọrọ ASK1 inhibitor (IC50 = 93 nM). Ọ na-egbochi LPS na-ebute ASK1 na p38 phosphorylation na astrocytes òké omenala ma na-egbochi neuroinflammation na ụdị EAE òké. MSC 2032964A bụ ihe dị ndụ n'ọnụ yana ihe na-abanye n'ụbụrụ.
CPD100604 Selonsertib Selonsertib, nke a makwaara dị ka GS-4997, bụ onye na-emechi ọnụ nke ihe mgbochi nke apoptosis na-achịkwa kinase 1 (ASK1), nke nwere ike igbochi mkpali, antineoplastic na mgbochi fibrotic. GS-4997 lekwasịrị anya ma jikọta na ngalaba catalytic kinase nke ASK1 n'ụzọ asọmpi ATP, si otú a gbochie phosphorylation na ịgbalite ya. GS-4997 na-egbochi mmepụta nke cytokines na-egbuke egbuke, na-edozi okwu nke mkpụrụ ndụ ihe nketa na-etinye aka na fibrosis, na-egbochi apoptosis gabigara ókè ma gbochie mgbasawanye cellular.
nke

Kpọtụrụ anyị

Ajuju

Akụkọ kacha ọhụrụ

  • Usoro 7 kachasị na nyocha ọgwụ na 2018

    Usoro 7 kacha elu na nyocha ọgwụ m...

    N'ịbụ ndị nọ n'okpuru nrụgide na-arịwanye elu mgbe niile ịsọ mpi na gburugburu ebe obibi akụ na ụba na nkà na ụzụ siri ike, ụlọ ọrụ ọgwụ na biotech ga-anọgide na-emepe emepe na mmemme R&D ha iji nọgide na-aga n'ihu ...

  • ARS-1620: Onye mmechi ọhụrụ na-ekwe nkwa maka ọrịa cancer KRAS-mutant

    ARS-1620: ihe mgbochi ọhụrụ na-ekwe nkwa maka K…

    Dị ka otu nnyocha e bipụtara na Cell si kwuo, ndị nchọpụta ewepụtala ihe mgbochi kpọmkwem maka KRASG12C nke a na-akpọ ARS-1602 nke na-eme ka ụbụrụ tumor regression na ụmụ oke. "Ọmụmụ ihe a na-enye na vivo ihe akaebe na mutant KRAS nwere ike ịbụ ...

  • AstraZeneca na-enweta nkwalite nchịkwa maka ọgwụ oncology

    AstraZeneca na-enweta nkwalite nchịkwa maka ...

    AstraZeneca nwetara nkwalite okpukpu abụọ maka pọtụfoliyo oncology ya na Tuesday, mgbe ndị na-ahụ maka US na European nabatara ntinye iwu maka ọgwụ ya, nzọụkwụ mbụ iji nweta nkwado maka ọgwụ ndị a. ...

Mkparịta ụka WhatsApp n'ịntanetị!